Clinical Significance of HER2-low Expression in Triple-negative Breast Cancer: A Retrospective Multicenter Study. - Iwai M; Horimoto Y; Wu R; Amaya K; Yamada A; Narui K; Yamada K; Kaise H; Ishikawa T (Cancer diagnosis & prognosis, 2025)